Dyne Therapeutics Inc (DYN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -35,583 | -149,291 | -97,505 | -54,923 | -24,968 |
| Depreciation Amortization | 1,030 | 3,668 | 2,590 | 1,633 | 730 |
| Accounts payable and accrued liabilities | -6,268 | 13,702 | 7,675 | 2,842 | 1,869 |
| Other Working Capital | -21,745 | 9,256 | -8,081 | -19,129 | 2,200 |
| Other Operating Activity | 11,827 | 3,102 | 3,826 | 5,034 | 1,776 |
| Operating Cash Flow | $-50,739 | $-119,563 | $-91,495 | $-64,543 | $-18,393 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -55,327 | -236,721 | -208,207 | -156,562 | -132,186 |
| PPE Investments | -1,401 | -3,618 | -1,628 | -747 | -9 |
| Purchase Of Investment | 52,077 | 98,010 | 72,178 | 22,500 | 3,820 |
| Sale Of Investment | 2,515 | 4,437 | 0 | 0 | N/A |
| Investing Cash Flow | $-2,136 | $-137,892 | $-137,657 | $-134,809 | $-128,375 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 18 | 157,821 | 157,732 | 157,275 | 157,250 |
| Financing Cash Flow | $18 | $157,821 | $157,732 | $157,275 | $157,250 |
| Beginning Cash Position | 203,519 | 303,153 | 303,153 | 303,153 | 303,153 |
| End Cash Position | 150,662 | 203,519 | 231,733 | 261,076 | 313,635 |
| Net Cash Flow | $-52,857 | $-99,634 | $-71,420 | $-42,077 | $10,482 |
| Free Cash Flow | |||||
| Operating Cash Flow | -50,739 | -119,563 | -91,495 | -64,543 | -18,393 |
| Capital Expenditure | -1,401 | -3,618 | -1,628 | -747 | -9 |
| Free Cash Flow | -52,140 | -123,181 | -93,123 | -65,290 | -18,402 |